Schrödinger
Schrödinger, Inc. is a company that uses computational platforms to discover novel molecules for drug development and materials design. Their software is licensed globally and they also leverage it for internal drug discovery programs. Schrödinger is currently advancing three clinical-stage oncology programs.
Funding Round: Grant
Funding Amount: $9.5M
Date: 18-Nov-2024
Investors: Bill & Melinda Gates Foundation
Markets: Pharmaceuticals, Biotechnology, Drug Discovery, Computational Chemistry, Software Development
HQ: New York, New York, United States
Founded: 1990
Website: https://www.schrodinger.com/
LinkedIn: https://www.linkedin.com/company/schr-dinger
Leave a Comment
Comments
No comments yet.